| Thursday, November 21, 2013 | |
|---|---|
| 18:00-19:30 | Opening Session |
| 19:30-20:30 | Welcome reception |
| Friday, November 22, 2013 | |||
|---|---|---|---|
| Hall A |
Hall B |
Hall C |
|
| 08:30-10:00 | Session A1Does the FRAX index really reflect society, and therefore, useful in the treatment of osteoporosis (OP)? | Session B1New therapeutic directions in osteoarthritis (OA) Partially supported by an unrestricted grant from IBSA Institut Biochimique SA |
|
| 10:00-10:30 | Coffee break & poster viewing |
||
| 10:30-12:00 | Session A2New insights in pathogenesis of rheumatoid arthritis (RA) |
Session B2Integration of herbal medicine in joint pain management: Utopia or reality? Supported by an unrestricted grant from Tilman S.A. |
|
| 12:00-12:50 | Lunch break | ||
| 12:50-14:20 | Session A3Bisphosphonates: How long is long enough? The concept of a drug holiday | Session B3Pain and physical activity: Friend or Foe? |
Free Communications: Muscles |
| 14:20-14:40 | Poster viewing | ||
| 14:40-16:10 | Session A4The future of osteoporosis treatment Endorsed and organized by the European Menopause and Andropause Society (EMAS) |
Session B4What is the real risk factor for OA: To be a woman or to develop an estrogen deficiency? |
Free Communications: Rheumatoid arthritis and pain |
| 16:10-16:30 | Coffee break & poster viewing |
||
| 16:30-18:00 | Session A5 From early to late post menopausal osteoporosis | Session B5Exercise and orthoses as treatment of OA: Can we expect a structural effect? |
Applying omics techniques to discover new OA biomarkers |
| Saturday, November 23, 2013 | |||
|---|---|---|---|
| Hall A |
Hall B |
Hall C |
|
| 08:30-10:00 | Session A6Sarcopenia: Impact of nutrition on muscle mass, strength and performance in older adults | Session B6Biomarkers to predict OA progression Supported by an unrestricted grant from Artialis |
|
| 10:00-10:30 | Coffee break & poster viewing |
||
| 10:30-12:00 | Session A7Latest updates and new treatments in BMJD in 2013 | Session B7Osteoarthritis and the future of therapy: Should we invest in basic research or in clinical care programs? |
Free Communications: Osteoporosis |
| 12:00-12:50 | Lunch break | ||
| 12:50-14:20 | Session A8Cartilage homeostasis and degeneration | Session B8Is there a better treatment than placebo for OA? |
Free Communications: Osteoporosis and osteoarthritis |
| 14:20-14:40 | Poster viewing | ||
| 14:40-16:10 | Session A9Innovations in surgery to repair musculoskeletal tissue Supported by an unrestricted grant from Synolyne S.A. |
Session B9New molecules in development |
Free Communications: Osteoarthritis |
| 16:10-16:30 | Coffee break & poster viewing |
||
| 16:30-18:00 | Session A10Managing bones in patients with cancer and liver diseases | Session B10Strategies in early RA and sponndyloarthropathies |
Free Communications: Joint Disease |
| Sunday, November 24, 2013 | ||
|---|---|---|
| Hall A |
Hall B |
|
| 08:30-10:00 | Session A11Different ways to evaluate and control RA | Session B11Controversial issues in Osteoporosis and Osteoarthritis Endorsed and organized by the Portuguese Society of Osteoporosis and Other Metabolic Bone Diseases (SPODOM) |
| 10:00 - 10:30 | Coffee break | |
| 10:30-12:00 | Session A12Hydrolysate collagen to treat OA: What's the evidence? |
Session B12Surgery of OA joints |
